These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34412102)

  • 61. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
    Duarte JD; Dalton R; Elchynski AL; Smith DM; Cicali EJ; Lee JC; Duong BQ; Petry NJ; Aquilante CL; Beitelshees AL; Empey PE; Johnson JA; Obeng AO; Pasternak AL; Pratt VM; Ramsey LB; Tuteja S; Van Driest SL; Wiisanen K; Hicks JK; Cavallari LH;
    Genet Med; 2021 Dec; 23(12):2335-2341. PubMed ID: 34282303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacogenetics Biomarkers Predictive of Drug Pharmacodynamics as an Additional Tool to Therapeutic Drug Monitoring.
    Haufroid V; Picard N
    Ther Drug Monit; 2019 Apr; 41(2):121-130. PubMed ID: 30883506
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gap between the US and Japan in coverage of pharmacogenomic biomarkers by health insurance programs: More coverage is needed in Japan.
    Hikino K; Fukunaga K; Mushiroda T
    Drug Metab Pharmacokinet; 2018 Dec; 33(6):243-249. PubMed ID: 30360950
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacogenetics: from bench to byte.
    Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH
    Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
    Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
    Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
    [No Abstract]   [Full Text] [Related]  

  • 66. Pharmacogenetics: a general review on progress to date.
    Daly AK
    Br Med Bull; 2017 Dec; 124(1):65-79. PubMed ID: 29040422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacogenomic considerations for medications in the perioperative setting.
    Jhun EH; Apfelbaum JL; Dickerson DM; Shahul S; Knoebel R; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenomics; 2019 Jul; 20(11):813-827. PubMed ID: 31411557
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review.
    Morris SA; Alsaidi AT; Verbyla A; Cruz A; Macfarlane C; Bauer J; Patel JN
    Clin Pharmacol Ther; 2022 Dec; 112(6):1318-1328. PubMed ID: 36149409
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels.
    Yoon DY; Lee S; Ban MS; Jang IJ; Lee S
    Transl Clin Pharmacol; 2020 Dec; 28(4):189-198. PubMed ID: 33425802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytochrome P450 genotype-guided drug therapies: An update on current states.
    Dong AN; Tan BH; Pan Y; Ong CE
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):991-1001. PubMed ID: 29858511
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evolving Role of Pharmacogenetic Biomarkers to Predict Drug-Induced Hematological Disorders.
    Pattanaik S; Jain A; Ahluwalia J
    Ther Drug Monit; 2021 Apr; 43(2):201-220. PubMed ID: 33235023
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
    Tuteja S; Salloum RG; Elchynski AL; Smith DM; Rowe E; Blake KV; Limdi NA; Aquilante CL; Bates J; Beitelshees AL; Cipriani A; Duong BQ; Empey PE; Formea CM; Hicks JK; Mroz P; Oslin D; Pasternak AL; Petry N; Ramsey LB; Schlichte A; Swain SM; Ward KM; Wiisanen K; Skaar TC; Van Driest SL; Cavallari LH; Bishop JR;
    Clin Transl Sci; 2022 Feb; 15(2):371-383. PubMed ID: 34562070
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.
    Luczak TS; Schillo PJ; Renier CM; Waring SC; Friday BB
    J Oncol Pharm Pract; 2022 Jun; 28(4):842-849. PubMed ID: 33853470
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A review of pharmacogenetics of adverse drug reactions in elderly people.
    Cardelli M; Marchegiani F; Corsonello A; Lattanzio F; Provinciali M
    Drug Saf; 2012 Jan; 35 Suppl 1():3-20. PubMed ID: 23446782
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.
    Ng D; Hong CS; Singh LN; Johnston JJ; Mullikin JC; Biesecker LG
    Genet Med; 2017 Mar; 19(3):357-361. PubMed ID: 27537706
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
    Solhaug V; Molden E
    Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
    [TBL] [Abstract][Full Text] [Related]  

  • 77. United States Emergency Department Use of Medications with Pharmacogenetic Recommendations.
    Limkakeng AT; Manandhar P; Erkanli A; Eucker SA; Root A; Voora D
    West J Emerg Med; 2021 Sep; 22(6):1347-1354. PubMed ID: 34787561
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis.
    Virelli CR; Mohiuddin AG; Kennedy JL
    Transl Psychiatry; 2021 Oct; 11(1):509. PubMed ID: 34615849
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients.
    Green DJ; Mummaneni P; Kim IW; Oh JM; Pacanowski M; Burckart GJ
    Clin Pharmacol Ther; 2016 Jun; 99(6):622-32. PubMed ID: 26693845
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development and implementation of a pharmacist-managed clinical pharmacogenetics service.
    Crews KR; Cross SJ; McCormick JN; Baker DK; Molinelli AR; Mullins R; Relling MV; Hoffman JM
    Am J Health Syst Pharm; 2011 Jan; 68(2):143-50. PubMed ID: 21200062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.